Form 4: Medicine Man Technologies Director Jonathan W. Berger Receives Stock Grant for Board Service

Director Jonathan W. Berger received 139,103 shares of Medicine Man Technologies, Inc. common stock as compensation for board service.

Summary

• Jonathan W. Berger, a director of Medicine Man Technologies, Inc., received 139,103 shares of common stock on June 28, 2024.
• The shares were granted as compensation for his service on the board of directors.
• The aggregate value of the shares was $54,250, based on the closing price of the common stock on the OTCQX Best Market on June 28, 2024.
• Following the transaction, Berger beneficially owns 587,980 shares of the company's common stock.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of a stock grant to a director, which is generally viewed neutrally. The grant itself can be seen as a positive sign of aligning director interests with shareholders, but it's not a major event that would significantly impact sentiment.

Positives

• The stock grant aligns the director's interests with those of the shareholders.
• The grant is a form of compensation that does not require immediate cash outlay from the company.

Industry Context

Stock grants to directors are a common practice in publicly traded companies as a form of compensation and to align their interests with those of the shareholders. This is especially common in smaller companies or those in emerging industries like cannabis, where Medicine Man Technologies operates.

Comparison to Industry Standards

• Stock grants to board members are a common practice across various industries, including cannabis.
• The size of the grant can be compared to similar companies in the cannabis sector to assess if it's within the typical range.
• Companies like Curaleaf, Trulieve, and Green Thumb Industries also use stock options and grants as part of their compensation packages for directors and executives.

Stakeholder Impact

• Shareholders may view the stock grant as a positive sign of aligning the director's interests with their own.
• The company's cash flow is not directly impacted as the compensation is in the form of stock.

Key Dates

Keywords

Medicine Man Technologies, Director, Stock Grant, Beneficial Ownership, Compensation, SHWZ, Berger, Board Service